ICAM2 and rheumatoid arthritis: Here, we confirmed that ICAM2, selected as an RA development associated gene by bioinformatics analysis, was an important target of ATT and mediated the inhibitory effect of ATT in RA‐FLSs, suggesting that ATT might be an effective antirheumatic drug.